LLY

NYSE · Pharmaceuticals

Eli Lilly and Co.

S&P 500 Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$1,152.93

+0.49 (+0.04%)

As of Sep 20, 9:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 30 79%

Hold 7 18%

Sell 1 3%

Price Target

Analyst Price Target +15.4% upside

Low Target $960.24

Average Target $1,330.33

High Target $1,470.76

Current Price $1,152.93

Current
$1,152.93

Target
$1,330.33

$960.24 $1,330.33 avg $1,470.76

Scenario Analysis

Bear Case

$960.24

-16.7%

Low target

Base Case

$1,330.33

+15.4%

Avg target

Bull Case

$1,470.76

+27.6%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$1,292.65

-10.8% from high

52-Week Low

$712.05

+61.9% from low

50-Day SMA

$1,141.44

+1.0% vs SMA

200-Day SMA

$1,021.54

+12.9% vs SMA

RSI (14)

48.5

Neutral

Target vs 52W High

$1,330.33

+2.9% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+15.4%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+10.9%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+8.4%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.6%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+176.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-37.9%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+193.9%